USPTO Examiner LEE ERICA SHENGKAI - Art Unit 3796

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18675446METHOD AND DEVICE FOR DELIVERING MULTI-PHASE DEFIBRILLATION THERAPYMay 2024January 2026Abandon2020NoNo
18587842LEADLESS BIOSTIMULATOR HAVING OVERMOLDED HEADER ASSEMBLYFebruary 2024November 2025Allow2030YesNo
18582575ROTATABLE ADAPTER FOR CONNECTING IMPLANTABLE MEDICAL LEADS TO TEST DEVICESFebruary 2024July 2025Allow1720YesNo
18433686FASTENING SYSTEM FOR AN ELECTRICAL STIMULATION GENERATORFebruary 2024March 2025Abandon1310NoNo
18539929SYSTEMS AND METHODS FOR ESTIMATING A POSITION OF A HEART PUMPDecember 2023April 2025Allow1620YesNo
18508061SELF-EXPANDING NERVE CUFF ELECTRODENovember 2023January 2025Abandon1410NoNo
18507403VESTIBULAR STIMULATION PROSTHESISNovember 2023September 2024Allow1010YesNo
18335116SYSTEMS AND METHODS FOR VAGUS NERVE STIMULATIONJune 2023July 2025Allow2530YesNo
18333416PATIENT TREATMENT SYSTEMS FOR SENSING CARDIAC DEPOLARIZATION AND/OR STIMULATING THE CAROTID SINUS NERVE, AND ASSOCIATED DEVICES AND METHODSJune 2023January 2026Allow3151YesNo
18327548AUTOMATIC LEAD LOCK FOR AN IMPLANTABLE MEDICAL DEVICEJune 2023July 2024Allow1410NoNo
18310307IMPLANTABLE COCHLEAR SYSTEM WITH INTEGRATED COMPONENTS AND LEAD CHARACTERIZATIONMay 2023July 2024Allow1510NoNo
18140387Treatment of Disorders Associated with InflammationApril 2023July 2024Allow1510YesNo
18306540TREATMENT OF PELVIC FLOOR DISORDERS USING TARGETED LOWER LIMB NERVE STIMULATIONApril 2023October 2025Abandon3020NoNo
18135057ATTACHMENT DEVICES AND ASSOCIATED METHODS OF USE WITH A NERVE STIMULATION CHARGING DEVICEApril 2023June 2025Abandon2660NoNo
18295709METHODS AND SYSTEMS FOR TERMINATING A PACEMAKER MEDIATED TACHYCARDIA (PMT)April 2023August 2024Allow1710YesNo
18088029MOISTURE ABSORBING SEAL FOR CATHETER FLUID SYSTEMDecember 2022December 2025Abandon3630NoNo
18061888MODULAR DEFIBRILATOR SYSTEMDecember 2022February 2026Abandon3820NoNo
18007791AUTOMATED EXTERNAL DEFIBRILLATOR AND METHOD FOR DISPLAYING STATE OF AUTOMATED EXTERNAL DEFIBRILLATORDecember 2022September 2025Allow3310YesNo
18059546ENERGY HARVESTING SYSTEM INTEGRITY MONITORINGNovember 2022March 2026Allow3910YesNo
17927593METHOD AND SYSTEM FOR COMMUNICATION BETWEEN A PLURALITY OF IMPLANTABLE MEDICAL DEVICESNovember 2022February 2025Allow2710NoNo
17999027SYSTEMS AND METHODS FOR VAGUS NERVE STIMULATIONNovember 2022March 2023Allow410NoNo
17984062ELECTRODE ARRAY FOR SPATIALLY RANDOM ELECTRICAL STIMULATIONNovember 2022February 2025Allow2741NoNo
18051190System and Method for Heart Pump Interrogation and InspectionOctober 2022February 2024Abandon1520NoNo
17972893Feedthrough With An Integrated Charging Antenna For An Active Implantable Medical DeviceOctober 2022April 2025Allow3011YesNo
17962771ROTATABLE LEAD CONNECTORSOctober 2022March 2026Allow4131YesNo
17951906ATTACHMENT DEVICES AND ASSOCIATED METHODS OF USE WITH A NERVE STIMULATION CHARGING DEVICESeptember 2022January 2024Abandon1610NoNo
17898511ROBOTIC SURGICAL SYSTEM AND CONTROL METHOD OF ROBOTIC SURGICAL SYSTEMAugust 2022December 2025Allow3930YesNo
17802978Method and kit for treating skin infectionsAugust 2022September 2025Allow3711NoNo
17894485Galvanic vestibular stimulation (GVS) systems, devices and methodsAugust 2022June 2024Allow2220NoNo
17890188OPTICAL STIMULATION SYSTEM WITH ON-DEMAND MONITORING AND METHODS OF MAKING AND USINGAugust 2022April 2024Allow2010NoNo
17800097SYSTEM AND METHODS FOR CLOUD-BASED INTERACTIVE GRAPHIC EDITING ON ECG DATAAugust 2022June 2025Abandon3401NoNo
17877537AORTOPULMONARY ELECTRICAL STIMULATOR-PRESSURE TRANSDUCERJuly 2022April 2025Allow3320YesNo
17866734IMPLANTABLE MEDICAL DEVICE AND METHOD OF FORMING SAMEJuly 2022August 2025Abandon3720NoNo
17758662PHOTOTHERAPEUTIC TREATMENT OF SKIN DISORDERSJuly 2022February 2026Abandon4331NoNo
17856046INTRACARDIAC ELECTROGRAM-BASED DIFFERENTIATION OF CONDUCTION SYSTEM AND MYOCARDIAL PACINGJuly 2022October 2025Allow3920YesNo
17840275NOVEL PERIPHERAL NERVE INTERFACE DEVICEJune 2022May 2025Allow3511YesNo
17779006CURRENT BIAS AS A CONTROL MECHANISM FOR ELECTRODE OPERATIONMay 2022December 2024Allow3100NoNo
17704815ARTIFICIAL RETINAL PROSTHESIS FOR PROVIDING COLOR VISUAL PERCEPTIONMarch 2022May 2025Allow3810NoNo
17704842ARTIFICIAL RETINAL PROSTHESISMarch 2022November 2025Allow4330YesNo
17686560SYSTEMS AND METHODS FOR ESTIMATING A POSITION OF A HEART PUMPMarch 2022September 2023Allow1820YesNo
17684768MONITORING STIMULATING ASSEMBLY INSERTIONMarch 2022February 2025Allow3521NoNo
17676394HEADER CORE FIXATION DESIGN FOR AN IMDFebruary 2022September 2024Abandon3040NoNo
17624392FASTENING SYSTEM FOR AN ELECTRICAL STIMULATION GENERATORJanuary 2022November 2023Allow2220YesNo
17566275MULTIPARAMETER NONINVASIVE SEPSIS MONITORDecember 2021August 2025Abandon4420NoNo
17645682MEDICAL DEVICE PATIENT ALERT USING HOUSING STIMULATION BASED ON SENSED EVENTDecember 2021December 2024Allow3640YesNo
17645661MEDICAL DEVICE PATIENT TWO-WAY COMMUNICATION BASED ON SENSED EVENTDecember 2021January 2026Abandon4950YesYes
17617120LIGHT THERAPY DIAGNOSTIC DEVICE AND METHOD FOR OPERATING THE SAMEDecember 2021July 2025Allow4311YesNo
17514161SUTURELESS ANCHORING MODULE AND METHOD FOR FIXING THE MODULE IN A PATIENTOctober 2021May 2025Allow4340NoNo
17498545NEUROSTIMULATION SYSTEM AND METHOD FOR AUTOMATICALLY ADJUSTING STIMULATION AND REDUCING ENERGY REQUIREMENTS USING EVOKED ACTION POTENTIALOctober 2021May 2025Abandon4460YesNo
17495952IMD ENCLOSURE FORMED USING DIELECTRIC MATERIALS INCORPORATING FEEDTHRU(S)October 2021January 2025Allow4041NoYes
17408931PREFORMED WIRE ROUTESAugust 2021April 2024Allow3150YesNo
17405804NEUROMODULATION THERAPY WITH CUSTOM INSTRUCTION SET ARCHITECTURE FOR A STIMULATION ENGINE SYSTEMAugust 2021February 2024Allow3020NoYes
17404102CATHETER DEVICE HAVING A COUPLING DEVICE FOR A DRIVE DEVICEAugust 2021March 2024Allow3120YesNo
17370153REPLACEABLE CARRIER FOR WEARABLE DEVICESJuly 2021July 2024Allow3620NoNo
17414746TISSUE ANCHORING ASSEMBLYJune 2021August 2024Allow3820NoNo
17348666ROTATABLE ADAPTER FOR CONNECTING IMPLANTABLE MEDICAL LEADS TO TEST DEVICESJune 2021March 2023Allow2130YesNo
17309686STIMULATING DEVICE INCLUDING AN ELECTRODE ARRAYJune 2021September 2024Abandon3910NoNo
17055023ROTOR, MAGNETIC COUPLING DEVICE, ELECTRIC MOTOR FOR A CARDIAC SUPPORT SYSTEM, PUMP UNIT FOR A CARDIAC SUPPORT SYSTEM, AND METHOD FOR PRODUCING A ROTORJune 2021December 2025Allow6021YesNo
17312861ELECTROMAGNETIC AND PHOTOBIOMODULATION DEVICES FOR TREATING EYE DISORDERS AND METHODS OF USING THE SAMEJune 2021December 2025Allow5411YesNo
17299264REAL-TIME ESTIMATION OF ELECTRODE ARRAY POSE DURING INTRA-COCHLEAR INSERTIONJune 2021August 2024Allow3931YesNo
17335279ROTARY INPUT FOR LEVER ACTUATIONJune 2021September 2025Allow5250YesNo
17294120APICAL INNER EAR STIMULATIONMay 2021November 2025Abandon5451YesNo
17243539ELECTRONIC DEVICE AND METHOD FOR DETERMINING INTENSITY OF LOW-FREQUENCY CURRENTApril 2021January 2025Allow4511YesNo
17242962RESILIENT HEAD MOUNTED DEVICE FOR NEUROSTIMULATION AND SENSING OF BODY PARAMETERSApril 2021January 2024Allow3331YesNo
17240799SUBCUTANEOUS DEVICE FOR PREVENTING AND TREATING ATHEROSCLEROSISApril 2021October 2023Allow3071YesNo
17222034COCHLEAR IMPLANT SYSTEM WITH ELECTRODE IMPEDANCE DIAGNOSTICSApril 2021August 2023Allow2800NoNo
17250963METHOD AND SYSTEM FOR MONITORING A SUBJECTApril 2021May 2025Abandon5020NoNo
17281698STRETCHABLE SENSING STRUCTURE AND METHOD FOR MANUFACTURING STRETCHABLE SENSING STRUCTUREMarch 2021May 2024Abandon3701NoNo
17206617METHOD FOR RAPIDLY DIAGNOSING A HEART CONDITION OF A PATIENT FROM ASSOCIATED ELECTROCARDIOGRAM ("ECG") DATAMarch 2021January 2024Abandon3401NoNo
17196389ATRIAL ARRHYTHMIA EPISODE DETECTION IN A CARDIAC MEDICAL DEVICEMarch 2021March 2025Allow4860YesNo
17158325PULSE GENERATOR WITH INDEPENDENT PANEL TRIGGERINGJanuary 2021August 2024Allow4331YesNo
17153645LEADLESS BIOSTIMULATOR HAVING OVERMOLDED HEADER ASSEMBLYJanuary 2021October 2023Allow3330YesNo
17149454MEDICAL DEVICE COMMUNICATION AND CHARGING ASSEMBLIES FOR USE WITH IMPLANTABLE SIGNAL GENERATORS, AND ASSOCIATED SYSTEMS AND METHODSJanuary 2021March 2025Allow5060YesNo
17148101DETECTING SHOCKABLE POLYMORPHIC VENTRICULAR TACHYCARDIAJanuary 2021February 2025Allow4950NoNo
17128444CERAMIC-TO-METAL JOINT FOR IMPLANTABLE PULSE GENERATORSDecember 2020December 2025Allow5970YesNo
17116702COCHLEAR IMPLANT SYSTEM WITH MEASUREMENT UNITDecember 2020February 2024Allow3840YesNo
17107435DEVICES AND METHODS FOR CONTROLLING TREMORNovember 2020March 2024Allow4030YesNo
17058256DEVICES, SYSTEMS AND METHODS FOR AURICULAR ACUPUNCTURENovember 2020July 2025Allow5651YesNo
17057733LIGHT THERAPY DEVICE HAVING LIGHT DIFFUSING FUNCTIONNovember 2020March 2024Abandon4010NoNo
17046235APPARATUS, SYSTEM, AND METHOD FOR THE OBJECTIVE EVALUATION OF CORPOREAL PAIN AND AUTONOMIC NERVE DYSFUNCTIONOctober 2020May 2024Abandon4310NoNo
17037241SYSTEMS AND METHODS FOR MONITORING NEUROSTIMULATION DOSINGSeptember 2020January 2026Abandon6041NoNo
17020621METHODS, IMPLANTABLE MEDICAL LEADS, AND RELATED SYSTEMS TO MONITOR AND LIMIT TEMPERATURE CHANGES IN PROXIMTY TO ELECTRODESSeptember 2020March 2024Allow4250YesNo
16944108MEDICAL DEVICE AND STORAGE BOX FOR MEDICAL ARTICLEJuly 2020August 2024Allow4840NoNo
16940183SYSTEM AND METHOD FOR REGULATING VITAL ENERGY (ZEN QI)July 2020May 2024Abandon4501NoNo
16912096CROSSOVER ADAPTER AND CROSSOVER LEADJune 2020March 2024Abandon4560NoNo
16758571ELECTRICAL SHIELDING IN IMPLANTABLE MEDICAL DEVICESApril 2020October 2023Allow4131YesNo
16649880DEVICE AND SYSTEM FOR PROVIDING PHYSIOLOGICAL DATA MONITORING OF PATIENTSMarch 2020December 2025Abandon6060YesNo
16816965VESTIBULAR STIMULATION PROSTHESISMarch 2020February 2024Abandon4761YesYes
16816581METHOD, SYSTEM AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR ESTIMATING ARRHYTHMIA BY USING ARTIFICIAL NEURAL NETWORKMarch 2020August 2024Abandon5331YesNo
16640466SYSTEMS AND METHODS FOR FACILITATING OPTIMAL ALIGNMENT OF COCHLEAR IMPLANT SYSTEM COMPONENTSFebruary 2020June 2024Allow5250NoNo
16722195METHOD AND DEVICE FOR DELIVERING MULTI-PHASE DEFIBRILLATION THERAPYDecember 2019October 2024Abandon5861YesNo
16622679NERVE STIMULATION AND MONITORING DEVICEDecember 2019February 2025Abandon6090YesNo
16688844IMPLANTABLE LEADNovember 2019January 2024Allow5070YesYes
16663773METHOD AND SYSTEM FOR CONSISTENT, REPEATABLE, AND SAFE CRYOSPRAY TREATMENT OF AIRWAY TISSUEOctober 2019August 2023Allow4640NoYes
16591874SYSTEMS AND METHODS FOR FLEXIBLE, HIGH-DENSITY OPTO-ELECTRONIC ARRAYSOctober 2019February 2024Allow5340YesNo
16526701SYSTEMS AND METHODS FOR FACILITATING SELECTING OF ONE OR MORE VECTORS IN A MEDICAL DEVICEJuly 2019May 2025Abandon6040YesYes
16286570METHOD, APPARATUS, SURGICAL TECHNIQUE, AND OPTIMAL STIMULATION PARAMETERS FOR NONINVASIVE & MINIMALLY INVASIVE AUTONOMIC VECTOR NEUROMODULATION FOR PHYSIOLOGIC OPTIMIZATION AND FOR THE TREATMENT OF OBESITY, CARDIAC DISEASE, PULMONARY DISORDERS, HYPERTENSION, AND OTHER CONDITIONSFebruary 2019November 2021Abandon3211NoNo
16212576SYSTEMS AND METHODS FOR PREVENTION OF PRESSURE ULCERSDecember 2018October 2023Allow5960YesNo
16198346MULTI-FUNCTIONAL SMART MOBILITY AID DEVICES AND METHODS OF USENovember 2018November 2024Abandon6070NoNo
16020876MULTI-MODAL STIMULATION FOR TREATING TREMORJune 2018June 2025Allow60120YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LEE, ERICA SHENGKAI.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
21.2%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
8
Allowed After Appeal Filing
2
(25.0%)
Not Allowed After Appeal Filing
6
(75.0%)
Filing Benefit Percentile
36.7%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner LEE, ERICA SHENGKAI - Prosecution Strategy Guide

Executive Summary

Examiner LEE, ERICA SHENGKAI works in Art Unit 3796 and has examined 69 patent applications in our dataset. With an allowance rate of 65.2%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 45 months.

Allowance Patterns

Examiner LEE, ERICA SHENGKAI's allowance rate of 65.2% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by LEE, ERICA SHENGKAI receive 4.26 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by LEE, ERICA SHENGKAI is 45 months. This places the examiner in the 14% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +24.4% benefit to allowance rate for applications examined by LEE, ERICA SHENGKAI. This interview benefit is in the 71% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 11.9% of applications are subsequently allowed. This success rate is in the 7% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.2% of cases where such amendments are filed. This entry rate is in the 21% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 58% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 83.3% of appeals filed. This is in the 77% percentile among all examiners. Of these withdrawals, 60.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 28.6% are granted (fully or in part). This grant rate is in the 16% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 79% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.4% of allowed cases (in the 79% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.